5-Pentyl-1,4-dioxan-2-one
Common Name: |
5-Pentyl-1,4-dioxan-2-one |
IUPAC Name: |
5-pentyl-1,4-dioxan-2-one |
Molecular Formula: |
C9H16O3 |
SMILES: |
CCCCCC1COC(=O)CO1 |
Inchi: |
1S/C9H16O3/c1-2-3-4-5-8-6-12-9(10)7-11-8/h8H,2-7H2,1H3 |
Inchi Key: |
AYJJZBHSZOCJJX-UHFFFAOYSA-N |
Cas No: |
65504-96-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
172.22 |
Mass (g/mol) |
172.11 |
Molar Refractivity |
45.63 |
Net Charge |
|
HBD |
|
HBA |
3 |
Rt Bonds |
4 |
Rings |
1 |
TPSA |
35.53 |
Hetero Atoms |
3 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
101.00 to 103.00 @ 15.00 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.89 |
LogP |
1.509 |
iLOGP |
2.36 |
XLOGP3 |
2.17 |
WLOGP |
1.51 |
MLOGP |
1.00 |
ESOL Log S |
-2.01 |
ESOL Solubility (mg/ml) |
1.68 |
ESOL Solubility (mol/l) |
0.01 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.55 |
Ali Solubility (mg/ml) |
0.49 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.13 |
Silicos-IT Solubility (mg/ml) |
1.28 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.81 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.476 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.831 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |